HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Anthony Caggiano, M.D., Ph.D., Vice President, Preclinical Development, will present at the upcoming New York Biotechnology Association (NYBA) Annual Meeting on Monday, April 20, 2009 at 9:20 a.m. Eastern Time at the Marriott Marquis Hotel in New York, NY. Dr. Caggiano will present an overview of Acorda’s clinical and preclinical pipeline as part of the NYBA Bioscience Industry Showcase.
